BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 19, 2008
View Archived Issues
LITHE, AMBITION studies reveal efficacy of tocilizumab in rheumatoid arthritis
Read More
Novel activin receptor type IIB proven effective in murine model of ALS
Read More
Preclinical profile of sanofi-aventis' novel histamine H3 antagonist reported
Read More
Antidepressant and antipsychotic activity reported with Wyeth's WS-50030
Read More
Medgenics encouraged by preliminary results with EPODURE in phase I/II study
Read More
Single and multiple doses of PGG-glucan safe and well tolerated in phase I studies
Read More
Lundbeck reviews quarterly developments
Read More
Genzyme and the ICGEB collaborate to advance treatments for malaria and other diseases
Read More
RegeneRX's RGN-259 used under compassionate use IND in corneal ulcers
Read More
Altus to submit NDA for Trizytek in pancreatic insufficiency in the first-half of 2009
Read More
Teva and Active Biotech complete enrollment in phase III ALLEGRO clinical trial of laquinimod
Read More
New contraceptive agents reported in recent Addex patent
Read More
Institute for OneWorld Health patent discloses new agents for diarrhea
Read More
Recent Pfizer patent describes novel treatments for lipoprotein disorders
Read More
Thallion initiates enrollment in phase II trial of TLN-232 for metastatic melanoma
Read More
Neuralstem to collaborate with Albert-Ludwigs-University in neural stem cell therapies
Read More
Debiopharm and Pharmaleads sign license agreement for Debio-0827
Read More
IDM Pharma receives CHMP recommendation for approval for mifamurtide
Read More
Phase IIb bicifadine study in diabetic neuropathic pain fails to meet primary endpoint
Read More
FDA grants orphan drug status to melphalan for cutaneous and ocular melanoma
Read More
Freedom-C oral treprostinil trial in PAH fails to meet primary endpoint
Read More
IDMC recommends continuation of Novogen's phase III trial of phenoxodiol
Read More
TorreyPines licenses to QR Pharma worldwide rights to compounds for Alzheimer's disease
Read More
Proteo starts phase II trial with Elafin in patients undergoing esophagectomy
Read More
Celator enrolls first patient in phase II CPX-351 study
Read More
JUPITER study: Rosuvastatin beneficial in patients with normal cholesterol but elevated CRP
Read More